Reiter Paul L, McRee Annie-Laurie, Gottlieb Sami L, Brewer Noel T
UNC Gillings School of Global Public Health, Chapel Hill, NC, USA.
Hum Vaccin. 2011 Jan 1;7(1):67-73. doi: 10.4161/hv.7.1.13500.
Immunization is a successful and cost-effective method for preventing disease, yet many adolescents do not receive recommended vaccines. We assessed correlates of uptake of three vaccines (tetanus booster, meningococcal, and human papillomavirus [HPV] vaccines) recommended for adolescent females. Methods. We examined cross-sectional data from 647 parents of 11-20 year-old females from North Carolina who completed the Carolina HPV Immunization Measurement and Evaluation (CHIME) Project follow-up survey in late 2008. Analyses used ordinal and binary logistic regression.
Only 17% of parents indicated their daughters had received all three vaccines. Eighty-seven percent of parents indicated their daughters had received tetanus booster vaccine, 36% reported vaccination against meningococcal disease, and 36% reported HPV vaccine initiation. Daughters aged 13-15 years (OR = 1.70, 95% CI: 1.09-2.64) or 16-20 years (OR = 2.28, 95% CI: 1.51-3.44) had received a greater number of these vaccines compared to daughters aged 11-12 years. Daughters who had preventive care visits in the last year (OR = 4.81, 95% CI: 3.14-7.34) or whose parents had at least some college education (OR = 1.90, 95% CI: 1.29-2.80) had also received a greater number of these vaccines.
Few daughters, particularly 11-12 years olds, had received all three vaccines recommended for adolescent females. Ensuring annual preventive care visits and increasing concomitant administration of adolescent vaccines may help increase vaccine coverage.
免疫接种是预防疾病的一种成功且具有成本效益的方法,但许多青少年未接种推荐的疫苗。我们评估了推荐给青春期女性的三种疫苗(破伤风加强疫苗、脑膜炎球菌疫苗和人乳头瘤病毒[HPV]疫苗)接种情况的相关因素。方法。我们检查了来自北卡罗来纳州647名11至20岁女性家长的横断面数据,这些家长在2008年末完成了卡罗来纳HPV免疫接种测量与评估(CHIME)项目的随访调查。分析采用有序和二元逻辑回归。
只有17%的家长表示他们的女儿接种了全部三种疫苗。87%的家长表示他们的女儿接种了破伤风加强疫苗,36%报告其女儿接种了预防脑膜炎球菌病的疫苗,36%报告其女儿开始接种HPV疫苗。与11至12岁的女儿相比,13至15岁(比值比[OR]=1.70,95%置信区间[CI]:1.09 - 2.64)或16至20岁(OR = 2.28,95% CI:1.51 - 3.44)的女儿接种的这类疫苗更多。去年进行过预防性保健就诊的女儿(OR = 4.81,95% CI:3.14 - 7.34)或其父母至少受过一些大学教育的女儿(OR = 1.90,95% CI:1.29 - 2.80)接种的这类疫苗也更多。
很少有女儿,尤其是11至12岁的女孩,接种了推荐给青春期女性的全部三种疫苗。确保每年进行预防性保健就诊以及增加青春期疫苗的联合接种可能有助于提高疫苗接种覆盖率。